The State Agency of Medicines (SAM) has been able to halve the time of expertise in case of change of marketing authorisation holder (MAH) to allow companies to change the MAH of medicines in a timely manner, thus, being...

The first cooperation meeting of the Estonian, Latvian, Lithuanian and Polish State Agencies of Medicines was held on the 7 and- 8th of September in Tartu. On the first day, heads of agency's met to discuss common issues...

The objective of the State Agency of Medicines (hereinafter - the Agency) is to work in the public interest so that the population has access to safe and effective medicinal products. In accordance with Sub-paragraph 146...

The State Agency of Medicines has published its Annual Report of the year 2022 which summarizes information regarding the operation of the Agency during the previous year. Some of the numbers that show Agency’s...

Please note that starting from 22 December 2022 the State Agency of Medicines has made changes in the Medicinal Product Register relating to the format of the published approved package leaflets and summaries of product...

The results of the survey conducted by the State Agency of Medicines (SAM) show that for medicines utilised in hospitals and other healthcare institutions electronic package leaflets are mostly used. Survey results are...

Dear clients of the State Agency of Medicines!

We are truly grateful for our collaboration and provided annual evaluation of accomplished work made by State Agency of Medicines (Agency).

We invite you to provide...

The State Agency of Medicines kindly informs that on 19 October 2022 from 9 am until 11 am the homepage of the Agency may not work (5 - 15 minutes) due to planned technical works. We apologize for the inconvenience!

Please note that starting from 7 September 2022 the State Agency of Medicines is transitioning to PDF (.pdf) format instead of the previous MS Word (.docx or .doc) format when publishing approved package leaflets...